| (1R,2R,3S,6S,7S)-Tricyclo[5.2.1.02,6]decane-3β-ol |
| (1R,2R,4S,5S)-7β-[[[(S)-2-Hydroxy-1-phenylethyl]carbonyl]oxy]-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonane 9-oxide |
153832-46-3 | Ertapenem |
667-66-3 | (3R,5R,8S,9S,10S,13S,14S,17R)-17-[(1R)-1,2-dihydroxyethyl]-3,17-dihydr oxy-10,13-dimethyl-2,3,4,5,6,7,8,9,12,14,15,16-dodecahydro-1H-cyclopen ta[a]phenanthren-11-one |
20685-55-6 | (3R,5R,8S,9S,10S,11S,13S,14S,17S)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12 ,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,11,17-triol |
131289-51-5 | (2R,3R,4S,5S,6S)-2-[(1R)-1,2-dihydroxyethyl]-6-[(2R,3S,4S,5S,6R)-6-[(1 R)-1,2-dihydroxyethyl]-2,5-dihydroxy-2-methyl-4-[(2R,3R,4S,5R,6R)-3,4, 5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-oxan-3-yl]oxy-oxane-3,4,5- triol |
92596-11-7 | (2R,3R,4S,5S,6S)-2-[(2R,3S,4R,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl) oxolan-2-yl]oxy-6-(sulfanylmethyl)oxane-3,4,5-triol |
| (1R,2R,4S,5S,7s)-7-[2-hydroxy-2,2-di(2-thienyl)acetoxy]-9-methyl-3-oxatricyclo[3.3.1.02,4]nonane |
2824-50-2 | (8R,9R,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-17-(2-methylprop-2-enyl)-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one |
1225-01-0 | (8R,9R,10S,13S,14S)-3-hydroxy-13-methyl-2,3,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydro-1H-cyclopenta[a]phenanthren-17-one |
| (3R,4R,6S,7S,11S,12R)-7,11-Dibromo-6-chloro-7,10,10-trimethyl-1-oxadispiro[2.0.5.4]tridecan-12-ol |
| (2R,3R,2'S,3'S)-1'-[(1S)-2-Hydroxy-1-methylethyl]-2α,2'β-diphenyl-3α-phenoxy-1,3'-biazetidine |
| (5β,8R,10α,13R,14S)-14-(Tigloyloxy)-3α-acetoxybeyera-15-ene-18-oic acid |
| (5β,8R,10α,13R,14S)-14-(Tigloyloxy)-3α-acetoxybeyer-15-en-18-oic acid methyl ester |
| (5β,8R,10α,13R,14S)-14-(Tigloyloxy)-18-hydroxybeyer-15-ene |
| (5β,8R,10α,13R,14S)-14-(Tigloyloxy)beyer-15-ene-3α,18-diol |
| (5β,8R,10α,13R,14S)-14-(Tigloyloxy)beyer-15-en-18-oic acid |
| (5β,8R,10α,13R,14S)-14-(Tigloyloxy)-3α,19-(isopropylidenebisoxy)beyer-15-ene |
| (1R,5R,6S,7S,8S)-7-Acetoxy-8-iodo-6-(methoxymethyl)-2-oxabicyclo[3.3.0]octan-3-one |
| (2R,3R,2'S,3'S)-1'-[(1S)-2-Hydroxy-1-methylethyl]-2α,2'β-diphenyl-3α-hydroxy-1,3'-biazetidine |
| (5β,8R,10α,13R,14S)-14-(Tigloyloxy)-3α-hydroxybeyer-15-en-18-oic acid |
| (1R,2R,6S,7S)-Tricyclo[5.2.1.02,6]deca-3,8-diene-9-carboxylic acid ethyl ester |
| (R)-2-[[(2R,4S,5S)-5-(tert-Butoxycarbonylamino)-2-benzyl-4-hydroxy-6-phenylhexanoyl]amino]-4-methylpentanamide |
| (1R,2R,6S,7S)-Tricyclo[5.2.1.02,6]deca-3,8-diene-8-carboxylic acid ethyl ester |
| (1R,2R,6S,7S)-Tricyclo[5.2.1.02,6]deca-3,8-diene-9-carbaldehyde |
| (1R,3R,5S,7S)-1,3,5,7-Tetramethyl-2-thiatricyclo[3.3.1.13,7]decane-4,6,8-trione |
| (1R,2R,6S,7S)-Tricyclo[5.2.1.02,6]deca-3,8-diene-8-carbaldehyde |
| (1R,2R,3S,5S)-3-(TERT-BUTYL-DIMETHYL-SILANYLOXY)-2-HEXYL-5-UNDECYL-CYCLOPENTANOL |
67843-79-2 | [1R-(1R*,5S*,9S*)]-4,11,11-trimethyl-8-methylenebicyclo[7.2.0]undec-3-en-5-yl acetate |
85136-29-4 | [1R-(1R*,5S*,9S*)]-4,11,11-trimethyl-8-methylenebicyclo[7.2.0]undecen-5-yl formate |
3672-15-9 | [(2R,3R,4S,5S)-3,4,5,6-tetrahydroxyoxan-2-yl]methoxyphosphonic acid |
654680-62-3 | (1R,3R,4S,6S)-4-TERT-BUTOXYCARBONYLAMINO-4,7,7-TRIMETHYL-BICYCLO[4.1.0]HEPTANE-3-CARBOXYLIC ACID |
| Rsk1, active (MAPKAP K1a, Kinase 1a)
|
| Rsk3, active, Recombinant, Human (Ribosomal S6 Kinase 3)
|
| Rsk1, active, Recombinant, Human (Ribosomal S6 Kinase 1, MAPKAP K1a, Kinase1a)
|
| Rsk2, active, Recombinant, Human (Ribosomal S6 Kinase 2, MAPKAP K1b, Kinase1b)
|
| Rsk1, active, Recombinant, Rat (Ribosomal S6 Kinase 1, MAPKAP K1a, Kinase1a)
|
| (2R,4'R,8'S)-5,7,8-Trimethyltocol |
| (2R,3R,4S)-2,3,4-Trimethoxy-5-hexenal |
| (1R,5R,7S)-Tricyclo[5.4.0.01,5]undecane-8-one |
| (2R)-2-[(4R,8S)-4,8,12-Trimethyltridecyl]-2,5,7-trimethyl-3,4-dihydro-2H-1-benzopyran-6-ol |
| (2R)-2-[(4R,8S)-4,8,12-Trimethyltridecyl]-2,7,8-trimethyl-3,4-dihydro-2H-1-benzopyran-6-ol |
| (2R,3R,4S)-2-Triphenylmethoxy-4-methyl-5-hexen-3-ol |
| (1R,3R,4S)-3-(Triethylsiloxy)-p-menthane |
| 3-[(1R,2R,4S)-1,7,7-Trimethylbicyclo[2.2.1]heptan-2β-yl]cyclohexanol |
92751-21-8 | (22R,23R,24S)-3β,22,23-Trihydroxy-5α-ergostan-6-one |
87734-68-7 | (22R,23R,24S)-3α,22,23-Trihydroxy-5α-ergostan-6-one |
| (2R)-2-[(4R,8S)-4,8,12-Trimethyltridecyl]-2,8-dimethyl-3,4-dihydro-2H-1-benzopyran-6-ol |
| (2R,3R,4S)-2,3,4-trihydroxy-4-(2-phenyl-2H-1,2,3-triazol-4-yl)butyl 4-methylbenzenesulfonate |
| (1R,4R,10S)-4,12,12-TRIMETHYL-9-METHYLENE-5-OXA-TRICYCLO[8.2.0.0(4,6)]DODECANE |
| (1R,2R)-1-Styryl-2-methyl-2-vinyl-1,3-propanediol |
| rSIVp55
|
| RSK-B protein |
175779-28-9 | (R)-TaClo |
175779-27-8 | (R)-TaClo |
| rRTNC
|
| RT1Ac (MHC Class I)
|
| rrTNF-a
|
| RSK3, CT (Ribosomal S6 Kinase 3)
|
| RSK2, CT (Ribosomal S6 Kinase 2)
|
130830-60-3 | (2R, 4R)-4-(TOLUENE-4-SULFONYLOXY)-1-[BENZYLOXYCARBONYL]-PYRROLIDINE-2-ETHYLCARBOXYLATE |
| (1R,4R,7-syn)-2α-Bromo-5-oxobicyclo[2.2.1]heptane-7-carboxylic acid |
| (1R,4R,7-syn)-2α-Chloro-5-oxobicyclo[2.2.1]heptane-7-carboxylic acid |
| (1R,4R,7-syn)-1,7-Dimethyl-7-(4-methyl-3-pentenyl)bicyclo[2.2.1]heptan-2β-ol |
| (1R,4R,7-syn)-6β-Bromospiro[bicyclo[2.2.1]heptane-3,2'-[1,3]dioxolane]-7-carboxylic acid methyl ester |
| (1R,4R,7-syn)-6β-Bromo-3-oxobicyclo[2.2.1]heptane-7-carboxylic acid methyl ester |
| [1R,4R,7-syn,(-)]-Bicyclo[2.2.1]heptane-2α,7-diol 2-acetate |
303176-46-7 | (1’R,2R)-2-(2’-Tosyl-1’,2’-dihydroxyethyl)-6-fluorochromane |
35985-98-9 | (1R,5R)-9-tosyl-9-azabicyclo[3.3.1]nona-2,6-diene |
155806-35-2 | (R)-(S)-JOSIPHOS |
| (RS)-KETOPROFEN, [3H(G)] |
| (1R,5R,8S)-8-[(Z)-2-Pentenyl]-2-oxabicyclo[3.2.1]octan-3-one |
| (2R,3R,4S,5Z)-2,3,4-Trimethoxy-6-(trimethylsilyl)-5-hexenal |
885677-91-8 | (1R,2R)-trans-2-(1-Piperidinyl)
cyclohexylaMine |
904316-35-4 | (1R,2R)-trans-2-AMino-1,2-dihydro-1-naphthol hydrochloride |
115563-64-9 | (1R,2R)-trans-2-AMino-1,2,3,4-tetrahydro-1-naphthol hydrochloride |
57496-61-4 | (1R,2R)-trans-1,2,3,4-Tetrahydro-1,2-naphthalenediol |
337376-51-9 | (1R,2R)-trans-1-Hydroxy-1,2-dihydro-2-naphthyl benzoate |
904316-32-1 | (1R,2R)-trans-2-(Boc-aMino)-1,2-dihydro-1-naphthol |
904316-40-1 | (1R,2R)-trans-1-Hydroxy-1,2,3,4-tetrahydro-2-naphthyl benzoate |
904316-33-2 | (1R,2R)-trans-2-(Boc-aMino)-1,2,3,4-tetrahydro-1-naphthol |
65376-04-7 | (-)-(1R,2R)-trans-2-(hydroxyMethyl)cyclohexanoic acid |
| (1R,2R)-trans-2-(1-Piperidinyl)
cyclohexylaMine hydrochloride |
| (2R 3R)-TRANS-3-PHENYLOXIRANE-2-METHANOL |
146504-07-6 | (1R,2R)-trans-N-Boc-1,2-Cyclohexanediamine |
169273-55-6 | 5-[3(R)-[[(2(R)-trans-Methyl-1,1-dioxotetrahydro-3(S)-thienyloxy)carbo nyl]amino]-4-(phenylthio)-2(R)-hydroxybutyl]-N-(1,1-dimethylethyl)octa hydrothieno[3,2-c]pyridine-6(R)-carboxamide |
| (2R, 4R)-TRANSHOMOPRO(4-OH)-OME |
163061-73-2 | (1R,2R)-(-)-TRANS-1-AMINO-2-INDANOL |
153215-70-4 | (-)-(2R,3R)-TRANS-2-HYDROXY-3-(4-PHENYLPIPERIDINO)-5-(2-FLUOROETHOXY)-TETRALIN |
161723-00-8 | (R,R)-3,4-TRANS-(N-BOC)-DIAMINOPYRROLIDINE |
1072-86-2 | (1R,2R)-TRANS-1,2-CYCLOHEXANEDIOL |
| (1R,2R)-TRANS-1,2-CYCLOPROPANE DICARBOXYLIC ACID MONOETHYL ESTER |
153215-71-5 | (-)-(2R,3R)-TRANS-2-HYDROXY-3-(4-PHENYLPIPERIDINO)-5-(2-TOSYLOXYETHOXY)-TETRALIN |
62617-70-3 | (2R,5R)-(-)-TRANS-2,5-DIMETHYLPYRROLIDINE |
| (1R,2R)-trans-2-Benzyloxycyclohexylamine hydrochloride |
| (R,R)-TRANS-2-(4-BROMO-BENZOYL)-CYCLOPENTANECARBOXYLIC ACID |
| (1R,2R)-TRANS-1,2-DIAMINOCYCLOHEXANE |
155975-19-2 | (1R,2R)-trans-N-Boc-2-Aminocyclohexanol |
1030390-38-5 | (1R,2R)-trans-1,2-Cyclopentanediamine dihydrochloride |
| 2(R)-[2(R)-(((trans-4-(1-Methylethyl)cyclohexyl)carbonyl)amino)-3-phenyl propionamido]-3-phenyl propionic acid. |